Wolfram syndrome (WS), also known as diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD), is a rare neurodegenerative disease. Bilateral optic atrophy is the most common ocular manifestation of the syndrome. Other ocular manifestations, such as color vision defects, visual field defects, nystagmus, strabismus, cataracts, and pigmentary retinopathy have also been described, albeit at lower frequencies. [1] Various types of cataracts have been reported in WS. We report a young male patient with bilateral, visually significant cataracts and optic atrophy, who was a known diabetic with hearing loss and genitourinary abnormalities. Surgical intervention for cataracts, followed by appropriate refractive correction, helped restore ambulatory vision for daily life in our patient despite optic atrophy.
Vogt–Koyanagi–Harada (VKH) disease is a systemic autoimmune disease typically managed with high-dose corticosteroids (>10 mg/day), which may pose a risk to maternal and fetal health if administered during pregnancy. We report a first-ever case of bilateral VKH disease in early pregnancy, who was successfully treated with an intravitreal dexamethasone implant in both eyes. There was rapid control of inflammation without maternal or fetal complications, and the patient delivered a healthy infant at term, free of congenital anomalies. This case highlights the potential of intravitreal dexamethasone as a safe and effective stop-gap measure, alternative to systemic corticosteroids. Treatment of VKH in pregnancy should be tailored to each patient depending on the gestational age of the patient and severity of inflammation, balancing disease control with maternal and foetal safety.
Acquired palsy of the trochlear nerve has been associated with closed-head injuries. We report the case of a 33-year-old male patient, who presented with complaints of torsional diplopia in the straight gaze which increased in the down gaze following head trauma. After a detailed ophthalmic evaluation, the patient was diagnosed with bilateral superior oblique (SO) palsy causing torsional diplopia. To counteract excyclotorsion, we have plicated the anterior one-third of the fibers of the SO in both eyes. Postoperatively, the patient was diplopia free and orthophoric, which maintained up to 3-month follow-up. Correction of excyclotorsion by selective plication of anterior fibers of the SO has already been reported in literature. However, the amount of plication to be performed for various degrees of torsion has not been appropriately described in the previously reported articles. We aim to improve the efficacy of plication anterior fibers of the SO by objective gradation.
A 54-year-old gentleman presented with diminution of vision in the left eye. Two weeks before presenting at our clinic, he underwent neodymium-doped yttrium aluminium garnet (Nd:YAG) capsulotomy to the same eye elsewhere for posterior capsular opacification (PCO). On slit-lamp examination, there was a central intraocular lens (IOL) pitting with brownish pigmented deposition over the pit, most probably the sessile macrophages post-inflammation, on direct illumination [Fig. 1a and b] and retroillumination [Fig. 1c]. Wolter et al.’s study revealed the presence of adherent protein membrane with excrescence over the surface of IOL with loosely attached sessile macrophages on the membrane.[1] The Nd:YAG laser operates in the infrared spectrum, with a wavelength of 1064 nm. Photodisruption is the result of intensely concentrated light radiation and is responsible for its impact on the tissue. The plasma undergoes a phase of expansion and collapse, producing an auditory shock wave.[2,3]Figure 1: Slit-lamp examination revealed central IOL pitting with brownish pigmented growth over the pit, most probably the sessile macrophages post-inflammation, on direct illumination (a, b) and retroillumination (c). IOL = intraocular lensDeclaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Financial support and sponsorship: Nil. Conflicts of interest: There are no conflicts of interest.